Abstract:Methyl 3,5-di-caffeoylquinate (3,5-diCQM) has been used for the treatment of various diseases in oriental medicine, but its effect on melanogenesis has not been reported yet. In this study, the molecular mechanism of 3,5-diCQM-induced melanogenesis was investigated. It was found that 3,5-diCQM induced synthesis of melanin pigments in murine B16F10 melanoma cells in a concentration-dependent manner. Treatment of cells with 3,5-diCQM for 48 h increased extracellular and intracellular melanin production and tyrosinase activity. The expressions of tyrosinase, tyrosinase-related protein 1 (TRP1), and TRP2 were up-regulated in a dose-dependent manner 48 h after 3,5-diCQM treatment. Western blot analysis showed that 3,5-diCQM increased the phosphorylation of p38 mitogen-activated protein kinase and cAMP responsive element binding as well as the expression of microphthalmia-associated transcription factor. In addition, 3,5-diCQM-stimulated cAMP production, and 3,5-diCQM-induced tyrosinase activity and melanin synthesis were attenuated by H89, a protein kinase A inhibitor. These results suggested that 3,5-diCQM-mediated activation of the p38 pathway may represent a novel approach for an effective therapy for vitiligo and hair graying.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of action of methyl 3,5 - dicaffeoylquinic acid (3,5 - diCQM) in inducing melanogenesis. Specifically, the study aims to reveal how 3,5 - diCQM increases tyrosinase activity and melanin synthesis by activating the p38 signaling pathway and inducing microphthalmia - associated transcription factor (MITF), thereby promoting melanogenesis. The ultimate goal of this study is to investigate whether 3,5 - diCQM can be a new potential therapy for white hair and hypopigmentation diseases of the skin. ### Research Background Melanin is a biological pigment found in the skin, hair, eyes, ears, brain and other parts of the human body. The pigmentation of the skin depends on the number, size, composition and distribution of melanocytes, or the activity of melanogenic enzymes. The production of melanin is crucial for scavenging free radicals and protecting metabolically active keratinocytes from environmental stimuli. The lack of epidermal melanin increases the risk of skin cancer and skin aging. In addition, the loss of skin pigment may lead to a decline in immunity, resulting in diseases such as vitiligo. ### Research Methods The researchers used the B16F10 mouse melanoma cell line and normal human epidermal melanocytes, and systematically studied the effect of 3,5 - diCQM on melanogenesis and its molecular mechanism through methods such as cell culture, Western blot analysis, cAMP concentration determination, cell morphological observation and cell viability measurement. ### Main Findings 1. **Increase in melanogenesis**: 3,5 - diCQM increased the extracellular and intracellular melanin content and tyrosinase activity in B16F10 cells in a dose - dependent manner. 2. **Up - regulation of tyrosinase and related protein expression**: After treatment with 3,5 - diCQM, the expressions of tyrosinase, tyrosinase - related protein 1 (TRP1) and TRP2 were significantly increased. 3. **Phosphorylation of p38 MAPK**: After treatment with 3,5 - diCQM, the phosphorylation level of p38 MAPK was significantly increased, while no significant changes were observed in the phosphorylations of ERK, JNK and AKT. 4. **Increase in cAMP level**: After treatment with 3,5 - diCQM, the intracellular cAMP level was significantly increased, which further activated protein kinase A (PKA), resulting in the phosphorylation of CREB and an increase in the expression of MITF. 5. **Effect of p38 MAPK inhibitor**: The p38 MAPK inhibitor SB203580 significantly reduced the enhancement of tyrosinase activity caused by 3,5 - diCQM, indicating that p38 MAPK plays a key role in 3,5 - diCQM - mediated melanogenesis. ### Conclusion 3,5 - diCQM increases tyrosinase activity and melanin production by activating the p38 signaling pathway and inducing the expression of MITF. These results suggest that 3,5 - diCQM may become an effective drug candidate for the treatment of vitiligo and white hair. Future studies will further explore its potential mechanisms and clinical applications.

Hyperpigmentation mechanism of methyl 3,5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase.

Suppression of Pax3–MITF-M Axis Protects from UVB-Induced Skin Pigmentation by Tetrahydroquinoline Carboxamide

Mechanistic Insights into the Stimulatory Effect of Melanogenesis of 4-Methylcoumarin Derivatives in B16F10 Melanoma Cells

Methyl-2-acetylamino-3-(4-hydroxyl-3,5-dimethoxybenzoylthio)propanoate suppresses melanogenesis through ERK signaling pathway mediated MITF proteasomal degradation

3,4,5-Tri-O-Caffeoylquinic Acid Promoted Hair Pigmentation Through β-Catenin and Its Target Genes

2, 3, 5, 4′-tetrahydroxystilbene-2-O-β-d-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation

Pigmentation Effects of Kaliziri Standard Extracts on Melanocytes, C57BL/6 mice of Hydroquinone- Induced and Guinea Pigs of Hydrogen Peroxide-Induced Hyperpigmentation Model

Interruption of p38 MAPK -MSK1-CREB-MITF-M pathway to prevent hyperpigmentation in the skin

Miglitol, an Oral Antidiabetic Drug, Downregulates Melanogenesis in B16F10 Melanoma Cells through the PKA, MAPK, and GSK3β/β-Catenin Signaling Pathways

Docosatrienoic Acid Inhibits Melanogenesis Partly through Suppressing the Intracellular MITF/Tyrosinase Axis

A 7-Hydroxy 4-Methylcoumarin Enhances Melanogenesis in B16-F10 Melanoma Cells

Anti-Inflammatory, Antioxidant, Moisturizing, and Antimelanogenesis Effects of Quercetin 3-O-β-D-Glucuronide in Human Keratinocytes and Melanoma Cells via Activation of NF-κB and AP-1 Pathways

6-Methylcoumarin Promotes Melanogenesis through the PKA/CREB, MAPK, AKT/PI3K, and GSK3β/β-Catenin Signaling Pathways

Targeting phosphorylation circuits on CREB and CRTCs as the strategy to prevent acquired skin hyperpigmentation

Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation

Di (Isoquinolin-1-Yl) Sulfane (DIQS) Inhibits Melaninogenesis by Modulating PKA/CREB and MAPK Signaling Pathways

Upregulation of Mitf by Phenolic Compounds-Rich Cymbopogon schoenanthus Treatment Promotes Melanogenesis in B16 Melanoma Cells and Human Epidermal Melanocytes

3,4,5-Trimethoxycinnamate thymol ester inhibits melanogenesis in normal human melanocytes and 3D human epidermal equivalents via the PGC-1α-independent PPARγ partial agonism

Dimethyl Itaconate Reduces α-MSH-Induced Pigmentation via Modulation of AKT and p38 MAPK Signaling Pathways in B16F10 Mouse Melanoma Cells

Inhibitory Effects of Polyphenol- and Flavonoid-Enriched Rice Seed Extract on Melanogenesis in Melan-a Cells via MAPK Signaling-Mediated MITF Downregulation

BCI-215, a Dual-Specificity Phosphatase Inhibitor, Reduces UVB-Induced Pigmentation in Human Skin by Activating Mitogen-Activated Protein Kinase Pathways